Ns 3% in cerebral oedema
| Condition | Role of 3% Saline |
|---|---|
| Traumatic brain injury (TBI) | First- or second-line agent to reduce ICP |
| Cerebral oedema in DKA (paediatric) | 5–10 mL/kg over 30 min (preferred over mannitol in haemodynamically unstable patients) |
| Subarachnoid haemorrhage with hyponatraemia | Corrects hyponatraemia + reduces cerebral oedema |
| Intracranial tumour / craniotomy | Intraoperative brain relaxation: 50–100 mL/h, titrated |
| Elevated ICP refractory to first-line measures | Adjunct or alternative to mannitol |
| Indication | Dose |
|---|---|
| Acute ICP elevation (general) | 30 mL of 23.4% NaCl bolus OR continuous 3% NaCl infusion |
| DKA-related cerebral oedema (children) | 5–10 mL/kg over 30 min |
| Hypertonic bolus (hyponatraemia-related oedema) | 100 mL 3% NaCl infused over 15–30 min (repeated up to 2×) |
| ICP Management Protocol | Target serum Na: 145–155 mEq/L |
| Elective craniotomy | 50–100 mL/h with hourly sodium surveillance |
| Feature | 3% Saline | Mannitol (20%) |
|---|---|---|
| Osmolarity | ~1026 mOsm/L | ~1098 mOsm/L (similar) |
| ICP reduction | At least as effective, possibly superior | Effective, gold standard |
| Haemodynamic effect | Expands intravascular volume (favourable in shock) | Causes diuresis → may worsen hypotension |
| Brain relaxation (craniotomy) | May be superior | Standard use |
| Risk in haemorrhage | Safer (no rebound oedema with cautious use) | Risk of rebound oedema at high doses |
| Preferred in | TBI + haemodynamic instability | ICP reduction without hypovolaemia |
"Hypertonic saline is at least as effective, if not more effective, than mannitol in treating elevated ICP. Furthermore, hypertonic saline may be more effective than mannitol for brain relaxation in elective craniotomy surgery." — Barash, Clinical Anesthesia, 9e